Fulgent Genetics
FLGT
Fulgent Genetics (FLGT) news
Recent news
Fulgent Genetics Inc: expects 2026 revenue $330.0-$340.0 mln; non-GAAP loss of about $2.22-$2.35 per share
AInvest Wire · Jul 30, 2026Fulgent Genetics Q2 adjusted EPS USD -0.58
AInvest Wire · Jul 30, 2026Fulgent Genetics sees FY adj loss/share about $2.22 to $2.35
AInvest Wire · Jul 30, 2026ImportantFulgent Genetics 30 adj EPS 14c, est. loss/shr 22
AInvest Wire · Nov 7, 2025Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.